ABL Bio Inc. (KOSDAQ: 298380)

ABL Bio Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	-	65,547	67,301	5,332
Other Revenue	0	0	-0	0
Revenue	32,321	65,547	67,301	5,332
Revenue Growth (YoY)	-52.08%	-2.61%	1162.19%	-
Cost of Revenue	61.87	46.25	83.76	47.98
Gross Profit	32,259	65,501	67,217	5,284
Selling, General & Admin	16,167	13,493	15,569	13,962
Research & Development	64,092	52,035	48,416	41,034
Operating Expenses	82,701	68,118	66,309	56,472
Operating Income	-50,442	-2,617	908	-51,188
Interest Expense	-209.66	-2,151	-1,326	-41.98
Interest & Investment Income	1,314	1,294	233.75	99.72
Currency Exchange Gain (Loss)	379.76	734.04	1,761	864.43
Other Non Operating Income (Expenses)	-40,325	-1,037	2,176	47.62
EBT Excluding Unusual Items	-89,284	-3,776	3,753	-50,218
Gain (Loss) on Sale of Investments	855.63	1,132	-592.13	6,666
Gain (Loss) on Sale of Assets	-2.64	-2.64	48	-5.83
Pretax Income	-88,431	-2,647	3,209	-43,558
Net Income	-88,431	-2,647	3,209	-43,558
Net Income to Common	-88,431	-2,647	3,209	-43,558
Shares Outstanding (Basic)	48	48	48	47
Shares Outstanding (Diluted)	48	48	48	47
Shares Change (YoY)	0.05%	0.58%	1.27%	-
EPS (Basic)	-1846.54	-55.32	67.46	-927.36
EPS (Diluted)	-1846.54	-55.32	67.46	-927.36
Free Cash Flow	-81,400	-34,102	70,076	-41,850
Free Cash Flow Per Share	-1699.73	-712.77	1473.24	-890.99
Gross Margin	99.81%	99.93%	99.88%	99.10%
Operating Margin	-156.07%	-3.99%	1.35%	-959.99%
Profit Margin	-273.60%	-4.04%	4.77%	-816.91%
Free Cash Flow Margin	-251.85%	-52.03%	104.12%	-784.87%
EBITDA	-48,000	-27.32	3,233	-49,029
EBITDA Margin	-148.51%	-0.04%	4.80%	-
D&A For EBITDA	2,442	2,590	2,325	2,158
EBIT	-50,442	-2,617	908	-51,188
EBIT Margin	-156.07%	-3.99%	1.35%	-

Source: S&P Capital IQ. Standard template. Financial Sources.